BackSmith & Nephew plc Overview
Smith & Nephew plc - ADR

Smith & Nephew plc Target Price

Analysts' average 12-month price target for Smith & Nephew plc is $31.

Get informed when a big investor buys or sells

+ Follow

Share Price

$30.19

Average Target Price

$30.932.4% upside

2 analysts in the last 4 months

High: $31.85 | Low: $30

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-11Bernstein$31.855.5% upsideOpen
2026-05-11Canaccord Genuity$300.6% downsideOpen
2026-04-24Canaccord GenuityCaitlin Cronin$326% upsideOpen
2025-10-14Bernstein$37.524.2% upsideOpen
2025-08-18Canaccord GenuityCaitlin Cronin$3619.2% upsideOpen
2024-11-04Canaccord GenuityKyle Rose$2710.6% downsideOpen

Smith & Nephew plc (SNN) FAQ

Smith & Nephew plc's target price stands at $31. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $31 for SNN implies 2.4% upside versus today's price ($30.19). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Smith & Nephew plc's target price evolved across reporting periods, while the comparison chart places SNN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Smith & Nephew plc's reading of $31 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.